Literature DB >> 23165212

Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.

Nathalia Meireles da Costa1, Agnès Hautefeuille, Marie-Pierre Cros, Matias Eliseo Melendez, Timothy Waters, Peter Swann, Pierre Hainaut, Luis Felipe Ribeiro Pinto.   

Abstract

Thymine DNA glycosylase (TDG) belongs to the superfamily of uracil DNA glycosylases (UDG) and is the first enzyme in the base-excision repair pathway (BER) that removes thymine from G:T mismatches at CpG sites. This glycosylase activity has also been found to be critical for active demethylation of genes involved in embryonic development. Here we show that wild-type p53 transcriptionally regulates TDG expression. Chromatin immunoprecipitation (ChIP) and luciferase assays indicate that wild-type p53 binds to a domain of TDG promoter containing two p53 consensus response elements (p53RE) and activates its transcription. Next, we have used a panel of cell lines with different p53 status to demonstrate that TDG mRNA and protein expression levels are induced in a p53-dependent manner under different conditions. This panel includes isogenic breast and colorectal cancer cell lines with wild-type or inactive p53, esophageal squamous cell carcinoma cell lines lacking p53 or expressing a temperature-sensitive p53 mutant and normal human bronchial epithelial cells. Induction of TDG mRNA expression is accompanied by accumulation of TDG protein in both nucleus and cytoplasm, with nuclear re-localization occurring upon DNA damage in p53-competent, but not -incompetent, cells. These observations suggest a role for p53 activity in TDG nuclear translocation. Overall, our results show that TDG expression is directly regulated by p53, suggesting that loss of p53 function may affect processes mediated by TDG, thus negatively impacting on genetic and epigenetic stability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23165212      PMCID: PMC3562302          DOI: 10.4161/cc.22843

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  65 in total

1.  Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1.

Authors:  Sophie North; Olivier Pluquet; Daniela Maurici; Fatiha El-Ghissassi; Pierre Hainaut
Journal:  Mol Carcinog       Date:  2002-03       Impact factor: 4.784

2.  DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.

Authors:  Stéphanie Courtois; Gerald Verhaegh; Sophie North; Maria-Gloria Luciani; Patrice Lassus; Ula Hibner; Moshe Oren; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-03       Impact factor: 9.867

Review 3.  TP53: a key gene in human cancer.

Authors:  D P Guimaraes; P Hainaut
Journal:  Biochimie       Date:  2002-01       Impact factor: 4.079

4.  Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover.

Authors:  Ulrike Hardeland; Roland Steinacher; Josef Jiricny; Primo Schär
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Sequence context at human single nucleotide polymorphisms: overrepresentation of CpG dinucleotide at polymorphic sites and suppression of variation in CpG islands.

Authors:  Daniel J Tomso; Douglas A Bell
Journal:  J Mol Biol       Date:  2003-03-21       Impact factor: 5.469

6.  Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.

Authors:  Hong-Lin Su; Steven S-L Li
Journal:  Gene       Date:  2002-08-21       Impact factor: 3.688

7.  The versatile thymine DNA-glycosylase: a comparative characterization of the human, Drosophila and fission yeast orthologs.

Authors:  Ulrike Hardeland; Marc Bentele; Josef Jiricny; Primo Schär
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

8.  Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice.

Authors:  Catherine B Millar; Jacky Guy; Owen J Sansom; Jim Selfridge; Eilidh MacDougall; Brian Hendrich; Peter D Keightley; Stefan M Bishop; Alan R Clarke; Adrian Bird
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 9.  Multiple mutations and cancer.

Authors:  Lawrence A Loeb; Keith R Loeb; Jon P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

10.  The main role of human thymine-DNA glycosylase is removal of thymine produced by deamination of 5-methylcytosine and not removal of ethenocytosine.

Authors:  Mika Abu; Timothy R Waters
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

View more
  13 in total

1.  miR-29b is an indicator of prognosis in breast cancer patients.

Authors:  Yoshiaki Shinden; Tomohiro Iguchi; Sayuri Akiyoshi; Hiroki Ueo; Masami Ueda; Hidenari Hirata; Shotaro Sakimura; Ryutaro Uchi; Yuki Takano; Hidetoshi Eguchi; Keishi Sugimachi; Yuko Kijima; Shoji Natsugoe; Koshi Mimori
Journal:  Mol Clin Oncol       Date:  2015-05-12

2.  Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.

Authors:  Tianli He; Jiayou Guo; Hongmei Song; Hongcheng Zhu; Xiaoke Di; Hua Min; Yuandong Wang; Guangzong Chen; Wangshu Dai; Jianhua Ma; Xinchen Sun; Jianxin Ma
Journal:  Pathol Oncol Res       Date:  2017-03-24       Impact factor: 3.201

3.  DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.

Authors:  F P Fortes; H Kuasne; F A Marchi; P M Miranda; S R Rogatto; M I Achatz
Journal:  Braz J Med Biol Res       Date:  2015-04-28       Impact factor: 2.590

Review 4.  Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis.

Authors:  Xuehe Xu; David S Watt; Chunming Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-14       Impact factor: 3.848

5.  Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.

Authors:  Daiane Teixeira DE Oliveira; Andre Luiz Ventura Savio; Joao Paulo DE Castro Marcondes; Tatiane Martins Barros; Ludmila Correia Barbosa; Daisy Maria Favero Salvadori; Glenda Nicioli DA Silva
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

6.  Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.

Authors:  Xuehe Xu; Tianxin Yu; Jiandang Shi; Xi Chen; Wen Zhang; Ting Lin; Zhihong Liu; Yadong Wang; Zheng Zeng; Chi Wang; Mingsong Li; Chunming Liu
Journal:  J Biol Chem       Date:  2014-02-14       Impact factor: 5.157

7.  Molecular dynamics of the full-length p53 monomer.

Authors:  Giovanni Chillemi; Pavel Davidovich; Marco D'Abramo; Tazhir Mametnabiev; Alexander Vasilievich Garabadzhiu; Alessandro Desideri; Gerry Melino
Journal:  Cell Cycle       Date:  2013-09-05       Impact factor: 4.534

8.  Retracted Article: Divergent synthesis of 5-substituted pyrimidine 2'-deoxynucleosides and their incorporation into oligodeoxynucleotides for the survey of uracil DNA glycosylases.

Authors:  Ai Tran; Song Zheng; Dawanna S White; Alyson M Curry; Yana Cen
Journal:  Chem Sci       Date:  2020-10-07       Impact factor: 9.825

9.  Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.

Authors:  Chunping Du; Nobuya Kurabe; Yoshitaka Matsushima; Masako Suzuki; Tomoaki Kahyo; Ippei Ohnishi; Fumihiko Tanioka; Shogo Tajima; Masanori Goto; Hidetaka Yamada; Hong Tao; Kazuya Shinmura; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2014-08-07       Impact factor: 7.701

10.  Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance.

Authors:  Jie Sun; Qi Shen; Haiqi Lu; Zhinong Jiang; Wenxia Xu; Lifeng Feng; Ling Li; Xian Wang; Xiujun Cai; Hongchuan Jin
Journal:  Oncotarget       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.